NewsBenzingaLivaNova Publishes Results In Neuromodulation: Technology At The Neural Interface Regarding Its CORE-VNS Trial Of Its VNS Therapy Devices LivaNova Publishes Results In Neuromodulation: Technology At The Neural Interface Regarding Its CORE-VNS Trial Of Its VNS Therapy Devices Benzinga 2026.10.23 13:06 (GMT+0) Open on Benzinga Other news PJT Partners Stock: Credit Crisis In AI Is A Golden Opportunity (NYSE:PJT) Mark Cuban Says AI Agents Can Be Like ‘Cockroaches’ That Find Ways Into Systems, But Defenders Can Fight Back With AI: ‘We’ve Always Had Hacks’ Nucor Has What It Takes To Capitalize On The Tailwinds In The Steel Market. (NYSE:NUE) Novartis AG (NVS) Discusses REMODEL Trial Results for Remibrutinib in Relapsing Multiple Sclerosis Transcript China Is Winning Tomorrow, But Losing Today Cathay General Bancorp Stock: Strong ROE Loan Re-Pricing In A Higher Rate (NASDAQ:CATY)
Mark Cuban Says AI Agents Can Be Like ‘Cockroaches’ That Find Ways Into Systems, But Defenders Can Fight Back With AI: ‘We’ve Always Had Hacks’
Novartis AG (NVS) Discusses REMODEL Trial Results for Remibrutinib in Relapsing Multiple Sclerosis Transcript
